Skip to main content
logo
Aurobindo Pharma Limited (NSE:AUROPHARMA)
India flag India · Delayed Price · Currency is INR
1,026.30
-19.30 (-1.85%)
Aug 28, 2025, 3:30 PM IST

Aurobindo Pharma Revenue

Aurobindo Pharma had revenue of 78.68B INR in the quarter ending June 30, 2025, with 3.98% growth. This brings the company's revenue in the last twelve months to 320.25B, up 7.76% year-over-year. In the fiscal year ending March 31, 2025, Aurobindo Pharma had annual revenue of 317.24B with 9.39% growth.

Revenue (ttm)
320.25B
Revenue Growth
+7.76%
P/S Ratio
1.86
Revenue / Employee
11.56M
Employees
27,707
Market Cap
596.08B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025317.24B27.22B9.39%
Mar 31, 2024290.02B41.46B16.68%
Mar 31, 2023248.55B14.00B5.97%
Mar 31, 2022234.55B-13.19B-5.32%
Mar 31, 2021247.75B16.76B7.26%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Sun Pharmaceutical Industries537.77B
Divi's Laboratories96.52B
Cipla274.80B
Apollo Hospitals Enterprise225.51B
Mankind Pharma129.10B
Zydus Lifesciences236.08B
Fortis Healthcare80.94B
Alkem Laboratories133.04B
Revenue Rankings

Aurobindo Pharma News

More News